Crinetics Pharmaceuticals (CRNX) Current Deferred Revenue (2022 - 2026)
Crinetics Pharmaceuticals' Current Deferred Revenue was $1.67 million in Q2 2026, down 12.3% from $1.9 million a year earlier but up 31.3% from the prior quarter.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Current Deferred Revenue (2022 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Crinetics Pharmaceuticals came in at $1.24 million, down 43.2% from FY2024.
- Current Deferred Revenue shows a three-year compound annual growth rate of -17.5% (FY2022 to FY2025).
- In earlier years, Current Deferred Revenue was $2.18 million in FY2024 (+5.8%), $2.06 million in FY2023 (-6.5%) and $2.2 million in FY2022.
- Quarterly Current Deferred Revenue has moved between $1.24 million (Q4 2025) and $2.56 million (Q2 2024) over five years.
- Compared with a year earlier, Current Deferred Revenue has declined for three straight quarters, with an average decline of 18.1% over the last seven quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q2 2024 (growth of 23.1%); the worst was Q4 2025 (a decline of 43.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Sep 30, 2023 | 1.66 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 2.32 Mn |
| Jun 30, 2022 | 2.54 Mn |
API Access
Crinetics Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();